Back

Clopidogrel following 1-month aspirin-free low-dose prasugrel monotherapy versus aspirin following 1-month DAPT after PCI for patients with ACS or HBR: Final 1-year results from the STOPDAPT-3

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Trial updates and other studies on percutaneous coronary intervention Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Hirotoshi Watanabe

Hirakata Kohsai Hospital, Hirakata (Japan)

4 More presentations in this session

Presentation thumbnail
Long-Term Outcomes with PCI Guided by Fractional Flow Reserve
Doctor C. Collet (New York, US)
Slides Video
Presentation thumbnail
Titanium-nitride-oxide-coated vs drug-eluting stents in acute coronary syndromes during five-year follow-up: an individual patient data meta-analysis
Doctor T. Mahendiran (Aalst, BE)
Slides Video
Presentation thumbnail
Physiology-guided complete versus culprit-only PCI in older MI patients
Associate Professor S. Biscaglia (Ferrara, IT)
Slides Video
Presentation thumbnail
A comparison of prolonged anticoagulation versus no anticoagulation after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction
Associate Professor Y. Yan (Beijing, CN)
Slides Video

Access the full session

Session thumbnail
Trial updates and other studies on percutaneous coronary intervention
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources